Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Precision radiotherapy for cancer of the pancreas: technique and results. [Photons and electrons]

Conference · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)
OSTI ID:6880416
Forty patients with locally extensive, unresectable adenocarcinoma of the pancreas received precision high dose (PHD) radiation therapy with a 45 MeV betatron. PHD radiotherapy was generally well tolerated. During treatment, only 7 patients experienced significant nausea, vomiting, diarrhea or anorexia. Late gastrointestinal radiation reactions were observed in 7 patients. Twelve patients received adjuvant chemotherapy. The projected survival of patients with unresectable pancreatic cancer treated with PHD radiotherapy is comparable to that of patients with resectable disease operated on for cure. The projected one year survival rate is 49%.
Research Organization:
Thomas Jefferson Univ. Hospital, Philadelphia, PA
OSTI ID:
6880416
Conference Information:
Journal Name: Int. J. Radiat. Oncol., Biol. Phys.; (United States) Journal Volume: 6:9
Country of Publication:
United States
Language:
English

Similar Records

Histopathological effects of intraoperative radiotherapy on pancreas and adjacent tissues: a postmortem analysis
Journal Article · Sun Jan 31 23:00:00 EST 1988 · J. Surg. Oncol.; (United States) · OSTI ID:5198812

Carcinoma of the pancreas: results of irradiation for unresectable lesions
Conference · Thu Jan 31 23:00:00 EST 1980 · Int. J. Radiat. Oncol., Biol. Phys.; (United States) · OSTI ID:5005642

Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma
Journal Article · Mon Nov 14 23:00:00 EST 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20706249